Answers are grounded in this paper and cite their sources.
Aim: COVID-19 is an important problem, and comorbidities may worsen the course of the disease. We aimed to investigate the role of comorbidities in COVID-19 patients hospitalized for outpatient treatment failure. Methods: Hospitalized COVID-19 patients were included in this study between March 1 and May 15, 2020. Those hospitalized due to treatment failure were defined as Group-1, and those hospitalized at first admission were defined as Group-2. Demographic information, comorbidities, laboratory data, and clinical results of the patients were examined. Results: A total of 514 patients were included in the study; 19.3% (n=99) were patients who worsened despite outpatient treatment (Group-1), and 80.7% (n=415) were hospitalized at first admission (Group-2). Group-1 cases were younger, but comorbidities were as high as the older Group-2 cases. We found that increasing age increases the risk of hospitalization (OR=1.02), bronchiectasis reduces the risk of hospitalization (OR=0,109), and other comorbidities have no impact on the risk of hospitalization. There was no difference between groups according to ICU transfer (Group-1: 6.1%, Group-2: 9.2%, p=0.32), hospital discharge rates (Group-1: 100%, Group-2: 96.6%, p=0,064), and mortality rates (p=0.064). In Group-1, leukocyte, thrombocyte, neutrophil, lymphocyte, eosinophil, monocyte, and basophil values were lower, and urea and D-Dimer values were higher than Group-2. Conclusions: This study identified age as a factor in increasing hospitalization in COVID-19 patients. On the other hand, the presence of bronchiectasis in patients appears to be a factor in reducing hospitalization. This situation raises a new question about whether the permanent dilation resulting from the damage caused by bronchiectasis in the bronchi could act as a preventive factor for the coronavirus. We believe that well-designed studies involving a large case series could lead the way in exploring this aspect further.
No takes yet. Share an insight, caveat, or question.
Özlem Soğukpınar (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: